AI and Healthcare

Healthcare data interoperability isn’t just about EMRs—it’s about patient survival, equity, and system sustainability. Jordan Johnson, MSHA, Founder of Bridge Oncology, breaks down the true scope of interoperability, from payer systems to AI-enabled radiotherapy. In this dynamic conversation with Dr. Sanjay Juneja, they explore how structured data, legal frameworks, and real-time analytics can res...

Is AI helping—or harming—the next generation of doctors? UCSF's Dr. Ben Rosner shares how AI is reshaping medical education in 2025. From tutor bots to clinical skill assessments, he explores the opportunities and pitfalls. Discover what 'de-skilling' means, and why educators need smart guardrails to guide AI integration.

AI is transforming discharge documentation. Dr. Ben Rosner of UCSF breaks down how large language models (LLMs) perform compared to physicians—and what that means for safety, education, and clinical workflows. Learn what “LLM as jury” could mean for quality control and how AI might de-skill future doctors if we're not careful.

AI is no longer just for clinicians. Emily Lewis, an AI thought leader, explains how AI is becoming a partner in patient care. From gamified self-care tools to multimodal education, she breaks down how technology can foster better communication and empower patients to take control of their health. She also explores the regulatory and data challenges involved in scaling AI for patient use. Featurin...

Disruptive innovation isn’t always what it seems—especially in healthcare. Bernardo Perez-Villa, Senior Innovations Engagement Partner at the Cleveland Clinic, shares a revealing look at the myths behind “first-in-class” innovation. Learn how startups create disruption, why big players wait to buy instead of build, and how to use Christensen’s framework to identify true disruption.

Why do so many digital health startups collapse? Dr. Bernardo Perez-Villa explains how a lack of real market validation derails innovation before it starts. Learn how to perform meaningful primary and secondary market research—from asking the right questions to clinicians to scanning Reddit and PubMed for real-world proof of need.

What separates scalable healthcare AI from hype? Dr. Bernardo Perez-Villa, Cleveland Clinic's Senior Innovations Engagement Partner, breaks down how to validate AI ideas, assess product-market fit, and build business models that survive reimbursement hurdles. Hosted by Dr. Sanjay Juneja.

Why rely on one method when three are better? Ezra CEO Emi Gal explains how combining imaging, liquid biopsy, and biomarkers creates a superior cancer screening protocol. He also shares how AI enables longitudinal tracking of lesions, reducing false positives and patient anxiety. Learn what makes Ezra’s approach uniquely effective in the fight against cancer.

Discover how Ezra uses FDA-cleared AI to transform MRI imaging. CEO Emi Gal explains how Ezra Flash speeds up scan times while improving quality, and how Ezra Assist aids radiologists with accurate annotations. Their AI-powered process makes full-body cancer screening possible in just 22 minutes—for under $500. Learn how this innovation is redefining medical imaging from acquisition to interpretat...

Can patients and clinicians be fairly rewarded for sharing healthcare data? Rajeev Ronanki, CEO of Lyric, discusses a future where AI-enabled tools empower community oncology practices with personalized digital agents. He outlines how reimbursement models can support physicians scaling their care using AI, and why rewarding patient data sharing is both ethical and economically sound.

Ezra CEO Emi Gal breaks down how AI is revolutionizing full-body MRI cancer screening. Learn how FDA-cleared tools accelerate scan time, assist radiologists, and empower patients with easy-to-understand reports—all for just $499. Discover why early detection matters, especially for younger adults, and how Ezra is scaling access to lifesaving diagnostics.

Rajeev Ronanki, CEO of Lyric and former Elevance Health executive, unpacks what the FDA’s AI initiative—Elsa—really means for drug innovation and regulation. Rajeev outlines how the agency can use data it already has to drive smarter, faster decisions. He draws powerful parallels to autonomous vehicles and urges the FDA to embrace AI while maintaining scientific rigor.

Trust in AI cannot exist without ethics - and ethics cannot exist without confronting data bias. Discover how artificial intelligence can become a force for safety, fairness, and innovation in healthcare when designed with integrity from the ground up. In this compelling exchange, Dr. Sanjay Juneja (sjunejamd.com) interviews Rajeev Ronanki (LinkedIn), CEO of Lyric, to uncover how AI can be enginee...

Rajeev Ronanki, CEO of Lyric and author of You and AI, joins Dr. Sanjay Juneja to discuss a radical rethinking of payment in healthcare. Instead of upgrading legacy systems, Rajeev proposes bypassing them using trusted AI agents that mediate between EMRs and payers. They explore real-time adjudication, the importance of trust and transparency, and how scalable AI tools can serve even community cli...

AI in healthcare brings breakthroughs - but also new legal and ethical risks. Who’s responsible when an AI-assisted diagnosis leads to harm? The licensed physician? The hospital? The tool’s developer? As AI becomes embedded in clinical workflows, this question becomes unavoidable. In this conversation, Mika Newton, CEO of xCures (https://www.linkedin.com/in/mikanewton/), interviews Dr. Colleen Lyo...

AI is reshaping clinical care, but can we apply trusted bioethical principles to its rapid adoption? This discussion explores how the Belmont Report’s three ethical pillars - autonomy, beneficence, and justice - remain essential as AI tools enter diagnosis, decision-making, and patient communication in modern healthcare. Hosted by Mika Newton, CEO of xCures, with expert insights from Dr. Colleen L...

Is AI in healthcare racing toward a crash? Discover what happens when innovation outpaces oversight, and why unchecked growth could lead to another industry meltdown. Mika Newton, CEO of xCures (https://www.linkedin.com/in/mikanewton/), and Dr. Colleen Lyons, clinical research ethicist at Champlain College (https://aicommons.champlain.edu/people/colleen-p-lyons/), unpack the consequences of deregu...

AI transforms how healthcare data is structured, analyzed and applied to clinical decision-making in life sciences. Discover how leading experts harness artificial intelligence to streamline clinical workflows, enhance data quality and accelerate actionable insights for healthcare providers and diagnostic organizations. Mika Newton, CEO of xCures, and Rajiv Haravu, SVP of Product Management at IMO...

AI is changing healthcare - but are we prepared for the hidden risks? From undermining critical thinking to damaging the human connection between providers and patients, AI’s unintended consequences deserve attention. Mika Newton (CEO, xCures) talks with Dr. Spencer Dorn (Vice Chair, UNC Department of Medicine) about the deeper risks AI poses across clinical care, system operations, and provider r...

Dr. Colleen Lyons, a clinical research ethicist with FDA experience, breaks down how ethics must evolve to meet the realities of AI in healthcare. From data bias to transparency, autonomy, and organizational responsibility, she offers an unflinching perspective on where we’re falling short - and what must change. Hosted by Mika Newton. Connect with Dr. Lyons: Champlain College Profile. More AI &am...

AI is transforming how clinicians handle information, starting with one of the most urgent issues in healthcare: too few providers, too much data, and not enough time. This conversation explores how AI can support physicians by summarizing patient records and medical literature, reducing burnout, and improving clinical decision-making. Hosted by Mika Newton, CEO of xCures (https://www.linkedin.com...

AI scribes are transforming how clinical notes are written, relieving physicians from time-consuming documentation and unlocking more patient-focused care. In this video, we explore what AI scribes really do, how they vary in capability, and which features actually move the needle in clinical practice. Hosted by Mika Newton, CEO of xCures (https://www.linkedin.com/in/mikanewton/), and featuring Dr...

Precision in surgery doesn’t start in the operating room - it starts with the data. Learn how advanced imaging, outcome-linked datasets, and AI-driven insights are reshaping surgical decisions and reducing repeat procedures. Dr. Sanjay Juneja speaks with Adrian Mendes, CEO at Perimeter Medical Imaging AI, to explore the critical relationship between imaging data and post-surgical outcomes in breas...

Missed margins and repeat surgeries drive up healthcare costs and stretch critical resources. OCT technology offers a path to smarter imaging and fewer reoperations, cutting costs while improving outcomes. Dr. Sanjay Juneja hosts Adrian Mendes, CEO of Perimeter Medical Imaging AI, to unpack how intraoperative OCT can drastically lower re-excision rates in breast cancer surgery. They explore the ri...

AI scribes promise relief from clinical documentation fatigue - but what are their limitations, hidden risks, and true return on investment? In a landscape saturated with new scribing technologies, understanding which tools integrate meaningfully with EHR systems and which merely transcribe surface-level dialogue is critical for healthcare leaders. Hosted by Mika Newton, CEO of xCures (https://www...